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Abstract
Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are thought to be the result of a gene duplication event early
in vertebrate evolution. To learn more about the evolution of these enzymes, we expressed in vitro, characterized, and
modeled a recombinant cholinesterase (ChE) from a teleost, the medaka Oryzias latipes. In addition to AChE, O. latipes has a
ChE that is different from either vertebrate AChE or BChE, which we are classifying as an atypical BChE, and which may
resemble a transitional form between the two. Of the fourteen aromatic amino acids in the catalytic gorge of vertebrate
AChE, ten are conserved in the atypical BChE of O. latipes; by contrast, only eight are conserved in vertebrate BChE. Notably,
the atypical BChE has one phenylalanine in its acyl pocket, while AChE has two and BChE none. These substitutions could
account for the intermediate nature of this atypical BChE. Molecular modeling supports this proposal. The atypical BChE
hydrolyzes acetylthiocholine (ATCh) and propionylthiocholine (PTCh) preferentially but butyrylthiocholine (BTCh) to a
considerable extent, which is different from the substrate specificity of AChE or BChE. The enzyme shows substrate
inhibition with the two smaller substrates but not with the larger substrate BTCh. In comparison, AChE exhibits substrate
inhibition, while BChE does not, but may instead show substrate activation. The atypical BChE from O. latipes also shows a
mixed pattern of inhibition. It is effectively inhibited by physostigmine, typical of all ChEs. However, although the atypical
BChE is efficiently inhibited by the BChE-specific inhibitor ethopropazine, it is not by another BChE inhibitor, iso-OMPA, nor
by the AChE-specific inhibitor BW284c51. The atypical BChE is found as a glycophosphatidylinositol-anchored (GPI-
anchored) amphiphilic dimer (G2
a), which is unusual for any BChE. We classify the enzyme as an atypical BChE and discuss its
implications for the evolution of AChE and BChE and for ecotoxicology.
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Introduction
Acetylcholinesterase (AChE; EC 3.1.1.7) hydrolyzes acetylcholine
attheneuromuscularjunctionofvertebrates.Highervertebratesalso
contain an evolutionarily related cholinesterase (ChE), butyrylcho-
linesterase (BChE, EC 3.1.1.8). The function of BChE is unknown
but is suggested to play a role in growth and development and to act
asascavengerofcholinergictoxinsaswellashavinganauxiliaryrole
in synaptic transmission [1,2]. The two ChEs may be distinguished
functionally both kinetically and pharmacologically: AChE hydro-
lyzes acetylcholine (ACh) and is virtually inactive on the larger
substrate butyrylcholine (BCh). BChE is less selective, hydrolyzing
both substrates comparably. AChE exhibits inhibition at high
substrate concentrations, while BChE shows substrate activation
instead [3]. The two enzymes may also be distinguished by their
susceptibility to diagnostic inhibitors [4].
Within species, AChE and BChE have ,50% amino acid
identity, and the overall tertiary structures of the two enzymes are
similar [5,6]. Individual amino acid residues involved in
determining the molecular basis of the differences in substrate
and inhibitor specificity of AChE and BChE have been identified
in the acyl pocket, located at the bottom of a deep catalytic gorge;
the peripheral site, located at the lip of the gorge; the oxyanion
hole; and the choline-binding site of the hydrophobic patch, also
located within the gorge [7–14]. Although the dichotomy between
AChE and BChE is generally clear in birds and mammals
[1,15,16], the two enzymes often more closely resemble one
another functionally in fish. In the cartilaginous fish, the electric
ray Torpedo marmorata [17], and the bony fishes, the plaice
Pleuronectes platessa [18], the flounder Platichthys flesus [19], and
perhaps the surgeonfish Acanthuras dussumieri [20,21], ChEs with
properties intermediate to and atypical of AChE and BChE are
found along with AChE. These enzymes have alternatively been
considered atypical ChEs [18,19] or atypical pseudo-cholinester-
ases (pseudo-ChEs) [17,20]; we are designating them as atypical
BChEs, as suggested by Whittaker [22]. Although a number of
cDNAs have been cloned for AChEs from these organisms,
molecular information about the atypical BChEs present is
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identified functionally and molecularly in the jawless fish, the
lamprey Petromyzon marinus [23] and the hagfish Myxine glutinosa
[24]. These observations suggest that AChE is the ancestral ChE
in the vertebrates and that an early gene duplication event and
subsequent divergent structural and functional evolution produced
the AChE and BChE of higher vertebrates [23,25].
AChE and BChE also exist in a variety of homomeric and
heteromeric molecular forms. The catalytic subunit of AChE is
found in different variants as a result of alternative splicing of the C-
terminus, producing R, H, and T (or AChER, AChEH, or AChET)
subunits [26,27]. The R, or read-through, transcript is rare and
producessolublenon-amphiphilicmonomers,G1
na[28].AChEHhas
a hydrophobic C-terminus, which is replaced by a glycopho-
sphatidyl-inositol phospholipid (GPI) anchor and produces amphi-
philic dimers, G2
a [29]. AChET is capable of forming G1
a,G 2
a,a n d
G4
na [29],aswellas‘‘tailed’’forms(thusthe Tsubunit)byassociating
with a transmembrane protein, the Proline-Rich Membrane
Attachment (PRiMA) [30] and the triple helical collagen Q (ColQ;
Q for queue, tail in French) [31,32]. In brain and at the
neuromuscular junction, PRiMA localizes AChE to the cell
membrane of synapses, forming G4
a (or G4
P). ColQ anchors AChE
to the junctional basal lamina of the neuromuscular junction,
producing A4,A 8,a n dA 12, which represent one, two or three
tetramersattachedtotheColQtriplehelix.WhileAChET isfoundin
all classes of vertebrates, AChEH exists in cartilaginous fish (Torpedo
spp.) [33], perhaps amphibians (Xenopus laevis) [34], and mammals
[35], but has not been reported in jawless or bony fish, reptiles, or
birds, raising questions about the evolution of this splice variant [26].
BChE does not exhibit alternative splicing and is considered to
be found solely as a T variant (BChET) [36,37] that also associates
with PRiMA and ColQ [30,36]. R and H variants of BChE have
not been reported. However, according to the Xenopus tropicalis
genomeproject [38] and otherevidence[34,39–42],anH variant of
BChE appears to be present in amphibian Xenopus species. The
atypical BChEs of T. marmorata and A. dussumieri are T variants
(BChET), assembling a collection of globular and asymmetric forms
[17,20]. In remarkable contrast, the atypical BChE of P. flesus is
BChEH, assembling only into GPI-anchored G2
a forms [19].
The medaka Oryzias latipes is a teleost fish that is of interest as a
vertebrate model system for developmental, genomic, and
evolutionary biology [43–45]. It was previously reported that O.
latipes possesses an AChE [46]. Here we report the cloning and
characterization of an atypical BChE, which has properties
intermediate to AChE and BChE, from O. latipes, and briefly
discuss the implications of the structure and function of this
enzyme for the evolution of the ChEs. Additionally, the presence
of ChEs with anomalous inhibitor specificities has ecotoxicological
implications for O. latipes [47,48] and other fish [49,50].
Results
Sequence Analysis Reveals Two ChEs in O. latipes
Two expressed sequences for ChEs are present in the O. latipes
genome: AChE (GenBank EST DK110600) and an enzyme that
we are classifying as an atypical BChE [45] (GenBank cDNAs
AV668390 and GU797251). The sequence for the AChE is
truncated near the carboxyl terminus and contains 561 amino
acids. The sequence of the mature polypeptide for the atypical
BChE from O. latipes contains 564 amino acids (Fig. 1). Pair-wise
BLAST alignments of sequences from the catalytic region of ChEs
show that the AChE from O. latipes clearly resembles T. californica
AChE rather than Homo sapiens BChE (68/80% identity/similarity
to AChE compared to 54/70% for BChE), while the atypical
BChE resembles both AChE and BChE more or less equally (46/
68% for AChE and 49/67% for BChE). A phylogenetic tree of
vertebrate and deuterostome invertebrate ChEs is shown in Fig. 2;
the AChE of O. latipes is found in the AChE clade, while the
atypical BChE of O. latipes is found in the BChE clade.
The members of the catalytic triad of ChEs are found as Ser203,
Glu330, and His461inthe AChE,and Ser203, Glu330, andHis443
in the atypical BChE. Of the fourteen aromatic amino acids that
line the catalytic gorge of vertebrate AChE, all are conserved in the
O. latipes AChE, and ten are conserved in the atypical BChE; in
contrast, eight are conserved in vertebrate BChE (Fig. 1; Table 1).
The O. latipes atypical BChE is missing two of the three aromatic
residues of the peripheral site of AChE, while BChE lacks all three.
Additionally, while AChE has two Phe residues in the acyl pocket
and BChE none, the O. latipes atypical BChE has one Phe (Fig. 1;
Tables 1, 2). As the O. latipes AChE conserves all ten aromatic
residues, it has two Phe residues in its acyl pocket.
The three pairs of conserved cysteine residues involved in intra-
chain disulfide bonding are also found as Cys69-Cys96, Cys257-
Cys268, and Cys405-Cys543 in the AChE; and Cys66-Cys93,
Cys257-Cys268, and Cys405-Cys520 in the atypical BChE of O.
latipes. Another cysteine (Cys540), near the carboxyl terminal that
normally mediates inter-chain disulfide bonding, is also conserved
in the atypical BChE (Fig. 1). The carboxyl terminus of the
enzyme is of the H-type (Fig. 3), characterized by a loosely defined
GPI anchor signal, including an v cleavage/attachment site
followed by a stretch of hydrophobic amino acids [51]. The H-
peptides show very little sequence homology to one another. We
did not find evidence for the existence of T-type carboxyl terminus
for the atypical BChE either as a T-exon in the genome or a T-
type carboxyl terminus in the ESTS of O. latipes. The truncated
AChE is missing its C-terminal sequence.
Diagnostic Inhibitors Show the Presence of Two ChE
Activities in Adult O. latipes
To demonstrate the presence of two ChE activities in O. latipes,
extracts from adult medaka were incubated with the inhibitors
physostigmine, which inhibits all ChEs; BW284c51, which inhibits
AChE selectively; and ethopropazine, which inhibits BChE
preferentially, and assayed for activity with ATCh and PTCh
[16,52,53]. Different dose-response curves were observed with the
two substrates for each inhibitor, suggesting the presence of at least
two ChE activities (Fig. 4). The dose-response curves for inhibition
of PTCh hydrolysis by BW284c51 and ethopropazine are
biphasic, clearly indicating the presence of two ChE activities,
presumably the AChE and atypical BChE identified in the O.
latipes genome project.
Kinetic Analysis of the Atypical BChE Indicates Its
Anomalous Properties
As we were interested in the functional characteristics of the
atypical BChE in O. latipes, we cloned and expressed in vitro a
cDNA for the enzyme in COS-7 cells. To determine the substrate
specificity of the enzyme, we assayed the hydrolysis of the
substrates acetylthiocholine (ATCh), propionylthiocholine (PTCh),
and butyrylthiocholine (BTCh) by the recombinant enzyme
(Fig. 5). The smaller substrates ATCh and PTCh are hydrolyzed
more or less equally, as indicated by the similar values of
kcat
Substrate/kcat
ATCh (Table 3); the larger BTCh is hydrolyzed at
about a quarter of the rate of the other two substrates. The Kms are
inversely proportional to the length of the acyl group, with BTCh
having the lowest Km. The highest catalytic efficiency (kcat/Km)i s
seen with PTCh. Additionally, ATCh and PTCh produce
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concentrations and b parameter values of ,1), although the
inhibition by PTCh is weak (Fig. 5; Table 3). BTCh does not
produce substrate inhibition. Overall, this pattern of substrate
hydrolysis is not typical of either AChE or BChE.
Pharmacological Analysis of the Atypical BChE Confirms
Its Anomalous Properties
Since the recombinant enzyme from O. latipes exhibited
anomalous kinetic properties, to characterize further this atypical
BChE activity, we determined the half maximal inhibitory
concentration (IC50) values of the enzyme for the inhibitors
physostigmine, which inhibits all ChEs; BW284c51, which inhibits
AChE preferentially; and iso-OMPA and ethopropazine, which
inhibit BChE preferentially. Physostigmine and ethopropazine
inhibit the enzyme at sub-mM concentrations; by contrast, much
higherconcentrations of BW284c51 and Iso-OMPAare required for
inhibition under the conditions tested (Fig. 6; Table 4). This pattern
of inhibition is also not characteristic of either AChE or BChE.
Analysis of Molecular Forms of the Atypical BChE further
Demonstrates Its Unusual Nature
ChEs exist in various homomeric and heteromeric molecular
forms depending, in part, on the nature of their carboxyl termini.
Since the amino acid sequence of the atypical BChE indicates an H-
type C-terminus, we performed velocity sedimentation on sucrose
gradients in the presence and absence of the non-ionic detergent
Triton X-100 to determine the molecular forms of the recombinant
enzyme produced in vitro by COS-7 cells. The extract contains G2
a
forms on the basis of the sedimentation coefficient (5.2560.10 S;
Mean6SE, N=6) and its shift to higher values in the absence of
detergentduetoaggregationoftheenzyme(8.9660.05;Mean6SE,
N=6) (Fig. 7). Digestion of intact COS-7 cells with phosphatidy-
linositol-specific phospholipase C (PIPLC) releases ,80% of the
surface enzyme activity. Spontaneous release of activity into the
supernatant during incubation in the absence of PIPLC was ,10%
(Fig. 8). These data indicate that the G2
a produced is a glycopho-
sphatidylinositol-anchored (GPI-anchored) form. It is unusual for
any BChE to be found as a GPI-anchored form.
Molecular Modeling of the Atypical BChE Illustrates Its
Differences with AChE and BChE
We built a homology model of the atypical BChE from O. latipes
based on the X-ray structures of H. sapiens BChE, and T. californica
and Drosophila melanogaster AChEs, in order to get a structural
understanding of the special pharmacological and enzymatic
properties of the enzyme (Fig. S1). A comparison of the active site
gorges is presented in Figure 9. The volume of the O. latipes
atypical BChE catalytic gorge (630 A ˚ 3) is much closer to that of H.
sapiens BChE (690 A ˚ 3) than that of T. californica AChE (410 A ˚ 3).
The difference in volume is related to the lack of aromatic residues
in three gorge subsites: the peripheral site, the acyl binding pocket,
and the choline binding pocket. T. californica AChE possesses three
conserved residues (Tyr70, Tyr121, and Trp279) that form an
aromatic peripheral binding site and restrict access to the gorge.
None of these aromatic residues is conserved in H. sapiens BChE
and only one aromatic residue is present in the O. latipes atypical
BChE (Tyr282), thus enlarging the gorge entrance (Table 1).
The acyl binding pocket of T. californica AChE is also smaller
than that of the atypical BChE from O. latipes, which is in turn
smaller than that of H. sapiens BChE, due to the respective
decreasing number of the phenylalanines shaping the pocket.
These differences are expected to change the selectivity of the
enzymes for substrates and inhibitors bearing large chains oriented
toward this pocket.
Another major difference between the O. latipes atypical BChE
and H. sapiens BChE and T. californica AChE is located in the
choline binding pocket. Phe330 (a tyrosine in mammalian AChE)
is substituted by a non-aromatic residue in both BChEs (Ala328 in
the H. sapiens BChE and Cys333 in the O. latipes atypical BChE).
Phe330 can adopt different conformations in the presence of
different ligands thus providing an efficient way to modulate the
shape and size of the choline binding pocket, even acting as a
molecular lid. The absence of a gating aromatic residue at this
position in BChE leaves the gorge wide open at all times. Notably,
just next to this position, the substitution of Met442 in H. sapiens
BChE by Ala440 in O. latipes BChE results in a significantly
widened choline binding pocket.
All things considered, the active site gorge of the atypical BChE
from O. latipes shares more structural features with that of H. sapiens
BChE than that of T. californica AChE, and it appears legitimate to
consider this enzyme as an atypical BChE from a structural point
of view.
Discussion
Overview
In addition to possessing an AChE, the medaka O. latipes has an
atypical BChE that is in many respects different from either
vertebrate AChE or BChE (Table 5). Of the fourteen aromatic
amino acids in the catalytic gorge of vertebrate AChE, ten are
conserved in the atypical BChE from O. latipes; by contrast, eight
are conserved in vertebrate BChE. These substitutions may
account for the intermediate nature of the atypical BChE.
Molecular modeling supports this interpretation. The enzyme
hydrolyzes ATCh and PTCh preferentially, but BTCh to a
considerable extent. In contrast, AChE is highly specific for ATCh
compared to BTCh and even PTCh, while BChE hydrolyzes the
larger substrates preferentially. The Kms for substrate hydrolysis by
the atypical BChE are inversely proportional to the length of the
acyl group, which is more a characteristic of BChE than AChE.
The enzyme shows substrate inhibition with the two smaller
substrates but not the larger substrate BTCh. By comparison,
AChE exhibits substrate inhibition, while BChE does not, but may
instead show substrate activation. The O. latipes enzyme also shows
an atypical pattern of inhibition by diagnostic inhibitors. It is
effectively inhibited by the ChE inhibitor physostigmine, typical of
all ChEs. However, although the atypical BChE is efficiently
inhibited by the BChE-specific inhibitor ethopropazine, it is not
inhibited by another BChE inhibitor, iso-OMPA, nor by the
AChE-specific bis-quaternary inhibitor BW284c51. The atypical
BChE is found as a GPI-anchored G2
a membrane-bound dimeric
form, also unusual for a BChE. We consider the enzyme an
Figure 1. Alignment of peptide sequences of Torpedo AChE, Human BChE, Medaka (O. latipes) AChE and Atypical BChE. Numbering of
the amino acid sequences is indicated on the right and starts with the amino acids of the mature polypeptide. Conserved (*) and similar (:.) residues
are indicated. Locations of the three elements of the catalytic triad are indicated (N). Single underlines link the cysteines participating in intrachain
disulfide bond. Sites of conserved aromatic amino acids lining the catalytic gorge in AChE are indicated withQorq ; those not conserved in medaka
(O. latipes) atypical BChE are marked withq .
doi:10.1371/journal.pone.0017396.g001
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and BChE in the vertebrates.
Comparison of Kinetic and Pharmacological Parameters
of the Atypical BChE from O. latipes with AChE, BChE, and
other Atypical BChEs in Vertebrates
Fluck [46] characterized the acylcholine hydrolyzing activity of
early embryos of O. latipes and found that ATCh, PTCh, and
BTCh were hydrolyzed at the relative rates of 1.0, 0.4, and 0.14,
respectively; that ATCh, at least, produced substrate inhibition;
and that 10 mM BW284c51 inhibited 90% of the activity, while
10 mM iso-OMPA inhibited only 10% of the activity. He
concluded that the enzyme present was AChE. Given the results
from the O. latipes genome project, which indicate two ChEs in the
genome; our results for BW284c51 and ethopropazine inhibition
of the ChE activity of adult medaka, which also suggest two ChEs;
and our data for the recombinant atypical BChE from O. latipes,i t
seems likely that both AChE and BChE were present in the
embryos studied by Fluck [46].
The Kms for substrate hydrolysis by the atypical BChE from O.
latipes are inversely proportional to the length of the acyl chain of
the substrate (Table 5). This relationship is seen in H. sapiens
BChE, which is representative of the typical vertebrate BChE; but
not T. marmorata, which is representative of vertebrate AChE. This
pattern is the most conserved characteristic of the atypical BChEs
from the flounder P. flesus, the plaice P. platessa, the surgeonfish A.
dussumieri, and the ray T. marmorata, suggesting that the non-
covalent stabilization of binding of substrate is determined
similarly in these enzymes. The acyl pocket, Phe288 and Phe290
in Torpedo spp. AChE, is implicated in this binding [8,12-14]. A
detailed discussion of the molecular basis of Km and other
parameters of substrate and inhibitor specificity is given in the
next section; since sequence information is only available for the
atypical BChE from O. latipes, it alone, among the atypical BChEs,
can be compared to AChE and BChE at the molecular level.
In contrast to the clear series seen for Km, the substrate
hydrolysis specificities of the enzymes, as defined by relative Vmax
or kcat values, do not show as consistent a pattern. Most of the
atypical BChEs hydrolyze ATCh preferentially and BTCh the
least. An exception is the O. latipes atypical BChE, which
hydrolyzes PTCh maximally, albeit only slightly faster than
ATCh. However, there are two additional exceptions to this
generalization: the P. platessa atypical BChE hydrolyzes BTCh
faster than PTCh, and the A. dussumieri atypical BChE hydrolyzes
BTCh only marginally better than does AChE. The variation in
relative Vmax or kcat values suggests that there are differences in the
stabilization in the covalent Michaelis complexes of substrates in
the various atypical BChEs. Such differences could be due to
differences in the nature of the conformation of the histidine of the
catalytic triad, which appears to be determined by different sets of
structural interactions in AChE and BChE [9,54].
There are also four different patterns of substrate inhibition
among the five atypical BChEs, indicating another heterogeneity
among the enzymes. The physiological relevance and molecular
mechanism of substrate inhibition are unclear [55–57]. Neverthe-
less, these differences in the enzymes are probably due to alterations
ofaminoacids,probablynon-aromaticsubstitutions,comprisingthe
peripheral site and/or other regions of the catalytic gorge in the
various enzymes that are important for substrate inhibition
[9,13,58,59]. It is notable that the substrate hydrolysis curve for
PTCh hydrolysis by the O. latipes atypical BChE, particularly in the
region of substrate inhibition resembles the curves for ATCh and
PTCh hydrolysis by the atypical BChE from A. dussumieri,a st h e
substrate inhibition levels off in both of the enzymes [21].
The atypical BChEs also show different patterns of sensitivity to
inhibitors; however, given the range of inhibitors used, and
focusing on the atypical BChE from O. latipes, it is possible to
compare their inhibition only for the AChE and BChE diagnostic
inhibitors BW284c51 and ethopropazine, and even for these
inhibitors the data are incomplete and a consistent pattern elusive.
Figure 2. Evolutionary relationships of 47 taxa. The evolutionary history was inferred using the Neighbor-Joining method. The optimal tree
with the sum of branch length = 8.65 is shown. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap
test (1000 replicates) is shown next to the branches. The tree is drawn to scale, with branch lengths in the same units as those of the evolutionary
distances used to infer the phylogenetic tree. The evolutionary distances were computed using the Poisson correction method [102] and are in the
units of the number of amino acid substitutions per site. All positions containing gaps and missing data were eliminated from the dataset (Complete
deletion option). There were a total of 257 positions in the final dataset. Phylogenetic analyses were conducted in MEGA4 [103]. Abbreviations and
references found in ESTHER [104]. Mammals: bovin (Bos taurus) cattle, rabit (Oryctolagus cuniculus) rabbit, human (Homo sapiens), canfa (Canis
familiaris) dog, felca (Felis catus) cat, mondo (Monodelphis domestica) possum, mouse (Mus musculus), ratno (Rattus norvegicus). Birds: chick (Gallus
gallus) chicken. Amphibians: xentr (Xenopus tropicalis) toad. Reptiles: bunfa (Bungarus fasciatus) snake, anca (Anolis carolinensis) anole. Bony fish
(teleosts): danio, danre (Danio rerio) zebrafish, eleel (Electrophorus electricus) electric eel, fugru (Fugu rubripes) puffer fish, tetng (Tetraodon
nigroviridus) puffer fish, gasac (Gasterosteus aculeatus) stickleback, oryla (Oryzias latipes) medaka, calmi (Callorhyncus milii) elephant fish. Cartilaginous
fish: torca (Torpedo californica) electric ray. Jawless fish: myxgl (Myxine glutinosa) hagfish. Urochordates: cioin (Ciona intestinalis) sea squirt, oikdi
(Oikopleura dioica) tunicate appendicularium. Cephalochordates: brafl (Branchiostoma floridae) amphioxus. Hemichordates: sacko (Saccoglossus
kowalevskii) acorn worm. Echinoderms: strpu (Strongylocentrus purpuratus) sea urchin.
doi:10.1371/journal.pone.0017396.g002
Table 1. Aromatic Amino Acids in the Catalytic Gorge of
Vertebrate ChEs.
Subsite
Torpedo
AChE
Oryzias
AChE
Oryzias
BChE
Homo
BChE
Peripheral Site Tyr70 Phe72 Met69 Asn68
Tyr121 Tyr124 Val124 Gln119
Trp279 Trp282 Tyr282 Ala277
Hydrophobic Patch
1 Trp84 Trp86 Trp83 Trp82
Tyr130 Tyr133 Tyr133 Tyr128
Phe330 Phe333 Cys333 Ala328
Phe331 Phe334 Phe334 Phe329
Acyl Pocket Phe288 Phe291 Leu291 Leu286
Phe290 Phe293 Phe293 Val288
Wall of Gorge Trp114 Trp117 Trp119 Trp114
Trp233 Trp236 Trp236 Trp231
Tyr334 Tyr337 Tyr337 Tyr332
Trp432 Trp453 Trp435 Trp430
Tyr442 Tyr463 Tyr445 Tyr440
Conserved aromatic residues are shown in bold. Torpedo AChE is representative
of all vertebrate AChEs and Homo BChE is representative of all vertebrate BChEs.
1Includes the choline-binding site.
doi:10.1371/journal.pone.0017396.t001
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most closely BChE, being sensitive to ethopropazine, but not
BW284c51; the BChE from T. marmorata is equally in/sensitive to
both inhibitors, while the BChEs from P. platessa and A. dussumieri
appear to be sensitive and resistant, respectively. These inhibitors
are sensitive to the presence or absence of aromatic amino acids
present in the choline-binding and peripheral sites, as well as to the
volumes of the catalytic gorges [12,14,60,61], which could be and
probably are different in the various atypical BChEs. Overall, the
variety of kinetic and pharmacological properties of these atypical
BChEs could be the result of natural selection exploring the
adaptive landscape for the various enzymes.
Molecular Basis of Substrate and Inhibitor Specificity in
the Atypical BChE from O. latipes in Comparison to AChE
and BChE
The atypical BChE from O. latipes maximally hydrolyzes ATCh
and PTCh almost equally and the larger substrate BTCh at about
a quarter of the rate of the two other smaller substrates. This
substrate specificity is not typical of either AChE, which
hydrolyzes ATCh maximally, PTCh adequately, but not BTCh
at all; nor BChE, which hydrolyzes the three substrates more or
less equally [15]. An important molecular determinant of ChE
specificity is the acyl pocket, which in vertebrate AChE is
characterized by two Phe residues (Phe288 and Phe290 in Torpedo
spp. AChE) [6], while in BChE these aromatic residues are
replaced by smaller aliphatic amino acids (Leu286(288) and
Val288(290) in H. sapiens BChE) [5]. Site-directed mutagenesis
studies suggest that the smaller amino acids relax the steric
hindrance of the aromatic rings and allow the accommodation and
proper positioning of larger substrates in the catalytic gorge for
nucleophilic attack by the active site serine [8,12,14]. The simple
fact that the atypical BChE from O. latipes has one of the two Phe
residues, Phe291 (Phe290 in Torpedo spp. AChE) but not the other,
present as Val288 (Phe290), seems sufficient to explain the
intermediate substrate specificity of the enzyme. Our molecular
modeling is consistent with this explanation.
In the mouse Mus musculus AChE, the F295L (F288L) mutation
has little effect on the Km for ATCh but lowers the Km for BTCh
30-fold [14]. In H. sapiens AChE, F295L has little effect on the Km
for ATCh or PTCh but decreases Km for BTCh 10-fold [12]. In
contrast, F295A also spares the Km for ATCh, but decreases Km for
PTCh and BTCh 4-fold and 33-fold, respectively. With respect to
Table 2. Amino Acid Sequences in the Region of the Acyl Pocket of Vertebrate AChE and BChE.
a
Enzyme Class Species Sequence
b
2882 90 400
AChE Mammalia Felis catus VFRFSFVPVV…DHNVVCP
Bos taurus VFRFSFVPVV…DHNVVCP
Oryctolagus cuniculus LFRFSFVPVV…DHNVVCP
Homo sapiens VFTFSFVPVV…DHNVVCP
Aves Gallus gallus VFRFAFVPVV…DHNVVCP
Reptilia Bungarus fasciatus IFRFPFVPVI…DHNVICP
Amphibia Xenopus tropicalis VFRFAFVPVP…DHNVICP
Osteichthyes Electrophorus electricus LFRFSFVPVI…DHNVICP
Danio rerio LFRFSFVPVV…DQNVICP
Oryzias latipes LFRFSFVPVV…DHNVICP
Chondrichthyes Torpedo spp. IFRFSFVPVI…DHNVICP
Agnatha Myxine glutinosa IFRFPFVPVV…DINVICP
BChE Mammalia Felis catus LLSVNFGPVV…DYNIICP
Bos taurus LLSVNFGPTV…DYNIICP
Oryctolagus cuniculus LLNFPFGPTV…DYNFICP
Homo sapiens PLSVNFGPTV…DYNFICP
Aves Gallus gallus LLHIYFCPTV…DYHIICP
Amphibia Xenopus tropicalis IIEMTFPPSV…DYNFICP
Xenopus tropicalis VIEVNFPPTV…DYNFICP
Osteichthyes Gasterosteus aculeatus IIITPFVPYV…DQYFVCP
Fugu rubripes LGGYPFVPVV…DVLFVCP
Oryzias latipes LLNFPFGPTV…DQMFVCP
aGenBank accession numbers (unless otherwise noted) are for AChE: F. catus (AF053485), B. taurus (AF061813) O. cuniculus (U05036), H. sapiens (AK223443), G. gallus
(U03472), B. fasciatus (U54591), X. tropicalis (ENSEMBL: ENSXETG00000017226), E. electricus (AF030422), Danio rerio (AJ251640), O. latipes (DK110600) Torpedo spp.
(X03439, X05497), M. glutinosa (U55003). For BChE: F. catus (AF053483), B. taurus (M62410), O. cuniculus (X52090), H. sapiens (M16541), G. gallus (AJ306928), X. tropicalis
(EG655516, CX359666), G. aculeatus (ENSEMBL: ENSGACG00000007230), F. rubripes (EMBL CAAB01000000), O. latipes (AV668390). Conserved Phe residues of acyl
pockets in bold; conserved Phe residue of BChE implicated in aromatic trapping is underlined.
bNumbering of acyl pocket residues: Phe288, Phe290, and Val400 in Torpedo spp. AChE. Conserved Phe (F) residues of acyl pockets in bold; conserved Phe residue of
BChE implicated in aromatic trapping is underlined.
doi:10.1371/journal.pone.0017396.t002
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ATCh and increases it 14-fold for BTCh. In H. sapiens AChE, the
F295L, A mutants do not affect appreciably the kcat for ATCh but
increase Km 400-fold. For wild type H. sapiens and M. musculus
AChE, the highest catalytic efficiency (kcat/Km) by far is seen for
ATCh; whereas, for the F295L, A mutants, the highest efficiency is
found for BTCh, with the efficiency for all three substrates within a
factor of three. These data are consistent with, if not identical to,
the results that we have obtained for the O. latipes atypical BChE,
which lacks the homologous Phe: all three substrates are
hydrolyzed appreciably, the Km is lowest for BTCh but lower for
PTCh compared to ATCh, and the catalytic efficiency for all the
substrates are within a factor of two. Thus, it appears that the
residue corresponding to Phe288 affects both the binding and
hydrolysis of substrate.
Furthermore, the two phenylalanines (Phe288 and Phe290) that
shape the acyl binding pocket of AChE, along with the aromatic
peripheral site residues, form an aromatic continuum with Phe330
and Phe331 of the hydrophobic patch. This aromatic network in
AChE has been suggested to play an important role in the
stabilization of the catalytic histidine [54]. But Phe288 and Phe290
are not conserved in H. sapiens BChE, and Phe288 is not conserved
in the atypical BChE from O. latipes (Leu291). Thus, this stabilizing
network is absent in BChE. However, the catalytic histidine of
BChE is well stabilized by interactions with an adjacent
phenylalanine, Phe398 in H. sapiens BChE or Phe403 in O. latipes
atypical BChE, which is absent in AChE (Val400 in T. californica
AChE). As a matter of fact, the catalytic histidine of H. sapiens
BChE has never been observed in an alternate conformation,
whereas such a conformation is not unusual in liganded AChE.
(See X-ray structure of VX-AChE (pdb entry 2VXR), tabun-
AChE (pdb entry 3DL4) and the NMR study of Masiah et al.
[62]). Interestingly, when the acyl loop of a cholinesterase bears an
aliphatic residue at the position equivalent to Leu291 in O. latipes
atypical BChE, there is an aromatic residue facing it, Phe401.
Reciprocally, when there is an aromatic residue at this position, as
with Phe288 in T. californica AChE, there is an aliphatic residue
facing it, Val400 (Table 2). This symmetrical situation probably
translates into a difference in the stability of the catalytic histidine
and the acyl pocket loop, which in turn might affect the stability of
the transition state during catalysis. It should be noted that in the
vast majority of invertebrate AChEs the acyl pocket appears to be
constructed in a different way with additional or alternative
aromatic residues playing a role in substrate specificity [63]. Thus,
modifications of the acyl pocket appear to occur throughout
animal evolution.
The atypical BChE of O. latipes is efficiently inhibited by
physostigmine and ethopropazine but not BW284c51 or iso-
OMPA, a pattern of inhibition different from AChE or BChE.
However, we think that the pattern more closely resembles BChE
rather than AChE with the inhibition by iso-OMPA being
exceptional. All ChEs are inhibited by physostigmine, so its
effective inhibition simply confirms that the enzyme is a ChE [16]
and does not need discussion. The sensitivity of AChE to the
slender, elongated bisquaternary inhibitor, BW284c51, is due to its
bivalent binding via cation-p and p-p interactions to aromatic
amino acids of the choline-binding site at the bottom of the gorge
and the peripheral site at its rim. In contrast, BChE has a number
of these residues replaced by aliphatics. In M. musculus AChE, the
peripheral site double mutant Y72N/Y124Q (Y70N/Y121Q)
increases Ki for BW284c51 69-fold [13]. Comparably, in H. sapiens
AChE the same double mutation increases Ki for the inhibitor 35-
fold. Moreover, the choline-binding site mutation Y337A
(Phe330A) increases the Ki 5-fold [60]. Making the reasonable
assumption of a synergistic effect for the mutations [60], a triple
Y72N/Y124Q/Y337A mutation encompassing both the periph-
eral and choline-binding sites could increase Ki by over two orders
of magnitude. Thus in the O. latipes atypical BChE, which has the
aliphatic substitutions Met69, Val124, and Cys333 at the
homologous sites, preventing the necessary cation-p and p-p
interactions via the aromatic residues, one might expect inefficient
inhibition by BW284c51, which is exactly what is observed.
Notably, the structure of the acyl pocket does not appear to
influence the binding of BW284c51 [13,14,60], consistent with the
situation in the atypical BChE of O. latipes.
The atypical BChE of O. latipes is inhibited by a low
concentration of the tricyclic amine-containing phenothiazine,
ethopropazine, which contains a bulky diethylamino-2-isopropyl
exocyclic group – inhibition typical of vertebrate BChE. Inhibition
of AChE and BChE by ethopropazine appears to be sensitive to
the nature of the residue corresponding to Phe330 of the aromatic
patch in Torpedo spp. AChE and to the volume of the active center
in BChE [13,61]. In M. musculus AChE, the Y337A (F330A)
mutation decreased Ki almost 2700-fold, making it comparable to
BChE [13], presumably because the side chain of Tyr337 sterically
hinders the binding of ethopropazine via an interaction between
the aromatic side chain of the residue and the diethylamino-2-
isopropyl moiety of the inhibitor. By contrast, the converse
mutations A328F and A328Y in H. sapiens BChE do not
substantially affect the Ki for the inhibitor [61]. There is, however,
a large difference in the gorge dimensions between AChE and
BChE, and this difference was used to explain the lack of effect.
The volume of the lower portion of the gorge in Torpedo spp.
AChE was reported to be 302 A ˚ 3, and in a modeled H. sapiens
BChE it was measured as 502 A ˚ 3. The van der Waals volume of
ethopropazine is 318 A ˚ 3, explaining why the drug does not bind
Figure 3. Alignment of peptide sequences of C-termini of representative vertebrate AChEs and BChEs. Conserved (*) and similar (:.)
residues are indicated. Putative V-cleavage sites are underlined. Putative hydrophobic transmembrane regions are boldly underlined. H. sapiens
(human), F. catus (cat), C. familiaris (dog), M. musculus (mouse), R. norvegicus (rat), X. tropicalis (clawed toad), O. latipes (medaka), G. aculeatus
(stickleback), F. rubripes (fugu), T. marmorata, electric ray.
doi:10.1371/journal.pone.0017396.g003
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increases the lower gorge volume to 338 A ˚ 3 and allows
ethopropazine to bind. In contrast, the A328Y and A328F
mutations in the H. sapiens BChE model only decrease the volume
of the lower gorge to 410 and 406 A ˚ 3, respectively, which allow
the gorge to still be large enough to bind ethopropazine easily [61].
Our own volume calculations using the narrower part of the
bottleneck to define the gorge entrance and taking into account
the conserved structural water molecule, gives an overall volume
of 690 A ˚ 3 for H. sapiens BChE, 630 A ˚ 3 for O. latipes atypical BChE
and 410 A ˚ 3 for Torpedo spp. AChE, in good agreement with the
observed trend for ethopropazine inhibition.
Iso-OMPA is an effective organophosphate inhibitor of BChE
but not AChE [52], where it is over 10,000 times less reactive [14],
and this selectivity appears dependent on the dimensions of the
active center of the enzyme, particularly the acyl pocket, affecting
the affinity of the enzymes for inhibitor. In M. musculus AChE, the
acyl pocket mutation F295L (F288L) increases ki 90-fold, F297I
(F290I) 200-fold, and the double mutant, over 500-fold for iso-
OMPA [14]. In H. sapiens AChE, similar, although more complex,
results were seen for the less bulky organophosphates, diisopropyl
phosphorofluoridate (DFP), diethyl phosphorofluoridate (DEFP),
andparaoxon[64].Replacementofaromaticaminoacidsintheacyl
pocket with aliphatic residues increases ki up to 130-fold, with
substitutions at Phe295 (Phe288) having the greater effect. The
differences in ki were primarily due to decreases in Kd with k2
relatively unaffected, suggesting that the substitutions relieved steric
interference in the binding of the inhibitors and enhanced enzyme
Figure 4. Concentration dependencies for inhibition of ATCh
and PTCh hydrolysis by extract from adult O. latipes. Adult fish
were extracted in HIS buffer and assayed with ATCh and PTCh in the
presence of various concentrations of the inhibitors (A) physostigmine,
(B) ethopropazine, and (C) BW284c51. Extracts were incubated with
inhibitor for 20 minutes prior to being assayed for activity with ATCh
(#) or PTCh (N).
doi:10.1371/journal.pone.0017396.g004
Figure 5. Substrate concentration dependencies for hydrolysis
of ATCh, PTCh, and BTCh by recombinant BChE from O. latipes.
Transfected COS-7 cells producing BChE were extracted in HIS buffer
and assayed with ATCh (N), PTCh (%), or BTCh (m) and fit as described
in Materials and Methods.
doi:10.1371/journal.pone.0017396.g005
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ethopropazine, converse site-directed mutagenesis of the acyl pocket
hasnot beenreportedforBChEandiso-OMPA.TheatypicalBChE
from O. latipes is relatively insensitive to, but is inhibited by iso-
OMPA. This result, aswellasthe substrate specificity of the enzyme,
is in good agreement with the reduction in size of the acyl pocket,
compared to BChE, associated with the presence of only one of the
two aromatic residues in the subsite in our molecular modeling. This
explanation, as well as the others offered on the molecular basis of
substrate and inhibitor specificity could be tested by site-directed
mutagenesis. In any event, it should be kept in mind that vertebrate
ChEs cannot always be characterized as AChE or BChE simply on
the basis of diagnostic inhibitor specificities [53], and that molecular
analysis can provide additional valuable information about the
nature ofChE activity.Since molecular dataare notavailableforthe
atypical BChEs from T. marmorata, P. flesus, P. platessa, and A.
dussumieri, we cannot compare at the molecular level the atypical
BChE from O. latipes with these enzymes.
Comparison of the Molecular Form of O. latipes Atypical
BChE with AChE, BChE, and other Atypical BChEs in
Vertebrates
The atypical BChE from O. latipes is a GPI-anchored G2
a
membrane-bound dimer and thus resembles a BChEH, possessing
an H-type C-terminus, which is removed upon the addition of the
GPI anchor. The atypical BChE of P. flesus is also a GPI-anchored
G2
a [19]. However, the atypical BChEs from T. marmorata and A.
dussumieri are BChET types since they are capable of assembling
into G1,G 2, and G4 molecular forms, and are able to interact with
the collagenic tail protein ColQ [17,20]. The forms of the P.
platessa enzyme are not known. While many vertebrate AChEs,
including Torpedo spp. and mammalian AChE are found as
AChET and AChEH as the result of alternative splicing, all
vertebrate BChEs are considered to be of the T-type [26]; the
atypical BChEs from O. latipes and P. flesus are the only certain
exceptions to this rule. The nature of the ChE activity in Xenopus
spp. is perplexing. A PIPLC-sensitive G2 AChEH has been
reported in X. laevis muscle [34,41], even though its substrate
specificity is characteristic of BChE [41], but the enzyme has been
classified as an AChE on the basis of diagnostic inhibition [39,40].
However, the ChE in X. laevis tadpoles was found to be resistant to
various carbamate and organophosphate inhibitors and to not
show inhibition by excess substrate [42]. Moreover, the genome
project for X. tropicalis indicates that only AChET sequences and
not AChEH sequences are present. In striking contrast though, a
BChEH sequence is found. The H-peptide is widespread in the
AChEs of invertebrates, although these sequences are not
homologous among the invertebrates nor with the vertebrates,
containing only a few functional similarities: a cysteine near the
carboxyl terminal that mediates inter-chain disulfide bonding in
the dimer, and a GPI anchor signal consisting of an v cleavage/
attachment site followed by a non-conserved stretch of hydropho-
bic amino acids [51]. These variant kinetic, pharmacologic, and
molecular form data among the atypical BChEs raise questions
about their evolution and the evolution of AChE and BChE in the
vertebrates.
The Evolution of AChE and BChE
In terms of substrate and inhibitor specificity and inhibition, it is
tempting to speculate that the atypical BChE of O. latipes and the
other atypical BChEs discussed represent a transitional form of
Table 3. Kinetic Parameters for Recombinant ChE from O. latipes.
a
Substrate Km mM Kss mM bk cat min
21 kcat
Substrate/kcat
ATCh kcat/Km M
21 min
21
ATCh 270618 516652 0
b 2.7660.11610
4 1.00 1.0360.05610
8
PTCh 156615 20612 0.6760.02 3.0760.24610
4 1.11 2.0060.05610
8
BTCh 72663 9 629 0.9260.07 0.7060.03610
4 0.25 0.9960.07610
8
aData are the mean 6 SE of 6–8 determinations.
bValues of b less than 0.02 are indistinguishable from zero.
doi:10.1371/journal.pone.0017396.t003
Figure 6. Concentration dependencies for inhibition of ATCh
hydrolysis by recombinant BChE from O. latipes. Transfected COS-
7 cells producing BChE were extracted in HIS buffer and assayed with
ATCh in the presence of various concentrations of inhibitors. Extracts
were incubated with inhibitor for 20 minutes prior to being assayed for
activity: physostigmine (#), ethopropazine (.) BW284c51 (N), iso-
OMPA (,). Data were fit to a three-parameter logistic function as
described in Materials and Methods.
doi:10.1371/journal.pone.0017396.g006
Table 4. IC50 Values for Inhibition of Recombinant ChE from
O. latipes.
a
Inhibitor IC50 M
Physostigmine 5.8560.79610
28
Ethopropazine 8.9860.75610
27
BW284c51 4.8060.82610
24
Iso-OMPA 4.5861.52610
23
aData are the mean 6 SE of 3–5 determinations.
doi:10.1371/journal.pone.0017396.t004
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vertebrates subsequent to a gene duplication event early in
vertebrate evolution. Assuming Darwinian gradualism, one would
expect that if AChE were the ancestral vertebrate ChE, with two
Phe residues in its acyl pocket, that upon gene duplication the two
residues would be replaced sequentially with an intermediate
enzyme having one of the Phe residues and decreased substrate
specificity, a property that is consistent with the putative role of
BChE in detoxification mechanisms and our data [1,2,65–67].
Subsequently, under selection pressure, the enzyme would lose its
second acyl pocket Phe residue to obtain the substrate specificity of
BChE in the higher vertebrates. Likewise, the atypical BChEs
show different intermediate patterns of substrate inhibition or lack
thereof, which could be interpreted as a transition to the complete
loss of substrate inhibition with all substrates, and the acquisition
of substrate activation, also a property consistent with the
detoxifying role of BChE. While substrate inhibition may be
physiologically relevant for the role of AChE in synaptic
transmission, it would not be adaptive toxicologically. The issue
of inhibitor sensitivity is more complicated. One might expect
selective pressures on a detoxifying enzyme to be directed towards
increased resistance to inhibitors. While non-aromatic substitu-
tions decrease the sensitivity of the enzyme to some inhibitors, they
increase the volume of the catalytic gorge in BChE, literally
opening it up to inhibition by bulkier inhibitors that cannot gain
access to AChE. Thus, there may be a tradeoff between decreased
substrate specificity and substrate inhibition, and decreased
inhibitor inhibition with the maximization of all three impossible.
By contrast, the larger gorge and increased sensitivity to some
inhibitors allows BChE to act as a stoichiometric scavenger of
natural and man-made carbamate and organophosphate inhibi-
tors [2]. Clearly, other non-aromatic substitutions in the acyl
pocket, in other subsites in the catalytic gorge, and in the
peripheral site, also producing kinetic and pharmacological
differences between the two enzymes have occurred in this
transition as the two enzymes diverged structurally and function-
ally subsequent to gene duplication [9,54,68,69].
Because of the possibility of three extensive (even genome-wide)
gene duplication events early in vertebrate evolution at (1) the
origin of the vertebrates, (2) the emergence of the jawed fish, and
(3) the appearance of the ray-finned fishes [70–72], the timing of
the putative gene duplication event producing vertebrate BChE
from AChE is uncertain. The jawless vertebrates, the lamprey P.
marinus and the hagfish M. glutinosa, appear to have only one ChE,
AChE [24,73], and there is evidence for two ChEs in the
cartilaginous jawed fish T. marmorata, AChE and an atypical BChE
[17]. Therefore, it is possible that a duplication of an ancestral
AChE gene accompanied the wide-spread gene duplication event
that coincided with the emergence of the jawed fish, with the
atypical and typical BChEs of bony fish and other derived
vertebrates descendents of this gene. However, given the genome
duplication event in the ray-finned fish lineage, it is possible that
these atypical BChEs are unique to the ray-finned fish and not
ancestral to the BChE of higher vertebrates, as the land
vertebrates descended from the lobe-finned fishes, represented
today by the lungfish and the coelacanth, which diverged from the
ray-finned fish prior to the duplication event [74]. Currently there
is not any information about ChEs from the coelacanth genome
project, but such information could shed light on the timing of the
gene duplication event and the evolutionary origins of BChE in
tetrapods. In any case, for the time being, the atypical BChE of O.
latipes can serve as a model for the evolutionarily intermediate ChE
between AChE and BChE.
Given that the poorly conserved H-transcripts are widespread in
the AChEs of invertebrates, while in vertebrates they are present
only in the AChE of the elasmobranch Torpedo spp. and mammals,
and apparently in a BChE in the amphibian Xenopus spp., but not
reported in reptiles or birds, Massoulie ´ et al. [26] stated that
sequences characteristic of a GPI-addition signal were ’’invented’’
on several occasions during evolution. We can now add the
presence of the H-peptide in the atypical BChEs of the teleosts P.
flesus and O. latipes. Combes et al. [75] speculated that the
conservation of splice sites at the C-terminus of AChE in insects,
nematodes, and vertebrates suggests that exon shuffling has
occurred at the 39end of ChE genes at various times throughout
evolution. Such shuffling is one mechanism for appearance of an
alternatively spliced exon [76]. Another explanation is exonization
[77,78]; indeed, the presence of read-through or R-transcripts [79–
Figure 7. Velocity sedimentation analysis of the molecular
forms of recombinant O. latipes BChE. HIS extracts from COS-7 cells
transfected with cDNA for BChE were sedimented on gradients
prepared in presence (N) and absence (#) of Triton X-100 as described
in Materials and Methods. Data are presented as the fraction of total
BChE activity on the gradient as a function of sedimentation coefficient.
doi:10.1371/journal.pone.0017396.g007
Figure 8. Release of BChE from transfected COS-7 cells by
PIPLC. Equal aliquots of transfected cells were harvested intact and
incubated at 37uC in PBS in the presence (N) or absence (#) of 4 units/
ml of PIPLC, and cells and supernatants were assayed for BChE activity
as described in Materials and Methods. Percent of the total activity
recovered that is present in the supernatant is indicated.
doi:10.1371/journal.pone.0017396.g008
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event, and the low abundance of such R-transcripts is consistent
with an exonization process [78]. Thus, it is possible that the
evolution of the C-termini of ChEs is independent of the evolution
of the catalytic subunit. Further discussion of the evolution of ChEs
can be found in Pezzementi and Chatonnet [82].
Ecotoxicological Implications
Pesticide use is a major concern in aquatic environments,
where runoff from agricultural and urban ecosystems impacts
their ecology. The major pesticides in use today are organo-
phosphate and carbamate acetylcholinesterase inhibitors, and
pyrethroid ion-channel agents [83,84]. These toxins are trans-
ported from terrestrial to aquatic ecosystems, placing the latter at
risk; thus, it is important to understand the effects of these
compounds on the resident vertebrate and invertebrate fauna
[85]. Inhibition of ChE activity in fish generally correlates with
mortality. There may also be sub-lethal behavioral and
physiological effects, including reduced swimming ability, and
altered feeding and social behavior. However, there are marked
species differences in these effects [86]. These differences could
be due to different levels of AChE and BChE in the nervous
Figure 9. Active site gorges of H. sapiens BChE (hBChE; pdb code 1p0i), T. californica AChE (TcAChE; pdb code 1ea5) and a homology
model of O. latipes atypical BChE (OlBChE). The side chains of key residues lining the gorges are represented as sticks (carbon in orange, oxygen
in red, and nitrogen in blue). The top of the gorge and the entrance to and exit from the enzyme are shown at the top of the figures. The acyl pocket,
which accommodates the acyl group of substrates, is comprised of residues F288 and F290 in T. californica AChE, L286 and V288 in H. sapiens BChE,
and L291 and F293 in O. latipes AChE. The central residue of the choline binding site at the bottom of the gorge is W84 in T. californica AChE, W82 in
H. sapiens BChE, and W83 in O. latipes atypical BChE. Substrates are bound between these two subsites. The solvent accessibility surface of the gorge
was calculated by taking into account highly conserved structural water molecules, using the software ‘‘HOLLOW’’ and represented as grey dots [99].
doi:10.1371/journal.pone.0017396.g009
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and differential sensitivity of the ChEs to inhibitors, including
the more recently used enantioselective organophosphates
[48,50,87]. The presence of atypical BChEs in some species of
fish probably contributes to these species-specific effects, and a
better understanding of the kinetics and pharmacology of these
atypical enzymes could provide insights into the toxic effects on
fish of ChE poisoning.
Materials and Methods
Ethics Statement
All animal procedures were conducted in strict adherence to the
European Council Directive of November 24, 1986 (86-609).
Approval for this study was provided by Comite ´R e ´gional
d’Ethique Languedoc Roussillon C34-172-10.
Materials
Dulbecco’s modified Eagle medium, fetal bovine serum, Opti-
MEM medium, and phosphatidylinositol-specific phospholipase C
(PIPLC) were purchased from Invitrogen, Carlsbad, California.
FuGene was obtained from Roche, Indianapolis, Indiana.
Acetylthiocholine (ATCh), butyrylthiocholine (BTCh), propio-
nylthiocholine (PTCh), [4-[5-[4-(dimethyl-prop-2-enyl-ammonio)-
phenyl]-3-oxo-pentyl]phenyl]-dimethyl-prop-2-enyl-azanium di-
bromide (BW284c51), 5-(3-carboxy-4nitro-phenyl)disulfanyl-2-
nitro-benzoic acid (DTNB), N-[bis(propan-2-ylamino)phosphory-
loxy-(propan-2-ylamino)phosphoryl]propan-2-amine (iso-OMPA),
10-(2-diethylaminopropyl) phenothiazine hydrochloride (ethopro-
pazine), and (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-
pyrrolo[2,3-b]indol-5-ol methylcarbamate (physostigmine) were
purchased from Sigma, St. Louis, Missouri. The high-affinity
ligand 7-[(diethoxyphosphoryl)oxy]-1-methylquinolinium iodide
(DEPQ) was a gift from Yacov Ashani.
O. latipes adults and embryos were from facilities at INRA. Fish
were maintained at 28uC on a 13-h light/11-h dark cycle.
cDNA cloning and sequence analyses
The cDNA clone Ola.23452 (Genbank AV668390) from an O.
latipes library was obtained from UniGene. The clone was
extended by PCR on the basis of the gene structure on
scaffold2582 in UCSC genome project, and the full cDNA
sequence (Genbank GU797251) was cloned into the expression
vector pCMV SPORT 6.1 (Invitrogen).
Sequences were aligned with Clustal W or Clustal X for
molecular modeling or phylogenetic analysis by the neighbor-
joining method [88]. Putative v cleavage/attachment sites and
downstream stretches of hydrophobic amino acids of H-type C-
termini of ChEs were predicted with PredGPI [89] and ProtScale
[90], respectively.
In vitro expression and extraction of enzyme
COS-7 monkey cells (American Type Culture Collection) were
grown in Dulbecco’s modified Eagle medium containing 10%
fetal calf serum. Cells were plated at a density of 2.5610
6 cells/75
cm
2 culture flask, incubated overnight, and transferred to
OptiMEM medium. FuGene was then used to transfect the cells
with 7.8 mg of DNA. The cells were then incubated for 48 h at
37
oC before the medium was removed and the cells extracted in
high ionic strength (HIS) buffer: 10 mM NaHPO4,p H7 ,1M
NaCl, 1% Triton X-100, 1 mM EDTA. Extracts were centri-
fuged at 20,000g for 20 min, and the supernatants were assayed
for ChE activity.
Measurement and analysis of BChE activity and inhibition
AChE activity was measured according to the method of Ellman
et al. [91] as modified by Doctor et al. [92] in 100 mM NaHPO4,
Table 5. Comparison of Available Kinetic and Pharmacological Parameters and Splice Variants of Vertebrate AChE, BChE, and
Atypical BChEs.
Parameter/Species
T.marmorata
AChE
a
O.latipes
BChE
P.flesus
BChE
b
P.platessa
BChE
c
A.dussumieri
BChE
d
T.marmorata
BChE
a
H.sapiens
BChE
Km
ATCh mM 0.05 0.27 2.20 0.90 1.24 0.4 1.4
e
Km
PTCh mM 0.2 0.16 1.03 0.15 0.24 0.15 0.97
e
Km
BTCh mM N.M.
j 0.07 0.32 0.14 0.06 0.05 0.91
e
Vmax
PTCh/Vmax
ATCh 0.25 1.11 0.29 0.41 0.61 0.59 1.66
e
Vmax
BTCh/Vmax
ATCh ,0.01 0.25 0.22 0.58 0.03 0.28 2.41
e
Substrate Inhibition
i +A,2P +AP,2B +APB 2AP,+B +APB 2APB -APB
IC50 Ethopropazine mM 158 0.90 12.6 N.D.
k N.D.
k 100 15.3
f
IC50 BW284C51 mM 0.04 480 63 0.79 Weak 100 651
g
Splice Variant
l H, T-type H-type H-type N.D.
k T-type T-type T-type
h
aData are from Toutant et al., [17]; the IC50 values are estimates.
bData are from Stieger et al. [19].
cData are from Lundin and represent titremetric measurement of the hydrolysis of the oxyesters rather than the thioesters of substrates [18].
dData are from Leibel and inhibition by BW284c51 is based on qualitative observations of the inhibition of ATCh staining of enzyme following non-denaturing gel
electrophoresis [21]. Splice variant data are from Leibel [20].
eData are from Davies et al. [100].
fData are from Ucar et al. [101].
gData are from Loewenstein-Lichtenstein et al.; IC50 was back calculated from a calculated Ki [69].
hData are from Blong et al. [37].
iA, acetylthiocholine; P, propionylthiocholine; B, butyrylthiocholine; +, inhibition by high substrate concentrations; -, no inhibition; substrate activation is not considered.
jN.M., not measureable.
kN.D., not determined.
lSplice variant determined by molecular forms present and sequence data when available.
doi:10.1371/journal.pone.0017396.t005
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some BChEs are inhibited by Triton X-100 [65], but the BChE
from O.latipes is not at theconcentrationsused inthis study (datanot
shown).ATCh,BTCh,and PTCh were used assubstratesat various
concentrations; for pharmacological analyses and assays of sucrose
gradients, the concentration of ATCh was 1 mM. The kinetic
parametersKm,Kss,b,an dVmax,weredetermined byusingSigmaPlot
to fit the data to the equation below as described by Radic ´ et al. [13]
and Kaplan et al. [9]. Kss is the dissociation constant for the binding
of substrate to a second site on the enzyme, and the parameter b
indicates the relative catalytic efficiency of the SES complex
compared to SE. If b ,1, the enzyme shows substrate inhibition; if
b.1, the enzyme shows substrate activation, and if b=1, Michaelis-
Menten kinetics is observed.
v~
1zbS ½  =Kss
1z S ½  =Kss

Vmax
1zKm=S

The turnover number kcat (Vmax/[Enzyme]) was determined by
enzyme titration with DEPQ [93] as described previously [63].
Values of IC50 for the inhibitors used were determined by
incubating enzymes with various concentrations of drug for
20 min and then assaying for enzyme activity in the presence of
ATCh. SigmaPlot was then used to fit the data to a three-
parameter logistic function, yielding IC50. Biphasic inhibition
curves were fit with GOSAfit. Since we were just looking for
classical diagnostic differential inhibition, it was not necessary to
determine ki or KI values for the inhibitors [4,24,52].
Velocity Sedimentation on Sucrose Gradients; PIPLC
Digestion
The molecular forms of ChE were analyzed by velocity
sedimentation in 5–25% isokinetic sucrose gradients prepared in
HIS buffer (with or without Triton X-100) containing 1 mg/ml
bovine serum albumin. Sedimentation was in an SW 41 rotor at
30,000–37,000 rpm for times satisfying the equation [(rpm)
26
t (h)] = 2.5610
10 as described previously [24]. Apparent
sedimentation coefficients were calculated relative to the sedimen-
tation of catalase (11.3 S). Data were plotted as fractional activity
of total ChE activity on the gradient as a function of sedimentation
coefficient: fractional activity on gradient = (activity in a given
fraction/total activity on gradient); sedimentation coefficient =
(fraction number) (11.3S/fraction number of catalase peak).
PIPLC digestion was performed by a modification of the method
of Gibney et al. [94]. These enzyme assays were performed in
Ellman’s solution prepared in phosphate-buffered saline.
Molecular Modeling
Sequence alignment was performed with ClustalX and
homology modeling was carried out using MODELLER 9v8
program [95]. MODELLER can implement comparative protein
structure modeling by satisfying spatial restraints in terms of
probability density functions. A 3D structural model of medaka
AChE was built by using the crystal structures of H. sapiens BChE
(pdb code 1p0i), T. californica AChE (pdb code 1ea5) and D.
melanogaster AChE (pdb code 1dx4) as structural templates.
Structural water molecules that are conserved among the three
templates were also retained in the modeling procedure. A series of
200 runs of MODELLER were carried out using standard
parameters, and the outcomes were ranked on the basis of the
internal DOPE scoring function. The model with the highest score
was chosen as the candidate model. Then, energy minimization
was performed using GROMACS 4.05 according to the software
protocol [96]. The final energy-minimized model and the
templates were aligned using Theseus [97] and analyzed in
PyMOL [98]. Active site gorge surfaces and volumes were
calculated using the software HOLLOW 1.1 [99] and taking into
account highly conserved structural water molecules. For each
structure, the active site entrance forms a bottleneck that was used
to delimit the volume of the gorge in the calculations.
Supporting Information
Figure S1 The pdb dataset for the model of O. latipes BChE.
(DOC)
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